“5am-ventures” Archives

in
Entry Author Date Location
Igenica Follows Genentech Into Antibody-Linked Cancer Drugs 04/11/14 San Francisco
Foresite Capital Reloads With New $300M Late-Stage Biotech Fund 04/01/14 San Francisco
East Coast Biotech Roundup: Neurophage, Boston Biotech, Insmed, & More 03/28/14 Boston
San Diego’s RuiYi Raises $15M for Pipeline of Biologic Therapeutics 03/28/14 San Diego
Flexion Prices IPO at $13, Heads to Nasdaq Tomorrow 02/11/14 Boston
Igenica Lands $14,000,000 Series C Financing Round 01/28/14 San Francisco
What Biotech Pros Will Be Chirping About at JP Morgan This Week 01/13/14 National
Flexion Files for IPO, Seeks $86M to Develop Osteoarthritis Drugs 01/08/14 Boston
5AM Ventures, an Early Stage Biotech VC Still Standing, Raises $250M 12/04/13 San Francisco
Atterocor Begins Phase 1 Trial for Adrenal Cancer Drug 11/01/13 Detroit Ann Arbor
Biodesy Garners $15,000,000 Series A Financing Round 10/18/13 San Francisco
Arvinas Obtains $19,250,000 Series A Financing Round 09/27/13 Boston
East Coast Life Sciences Roundup: Syndax, Enteris, Invivo, & More 08/30/13 Boston
Audentes, Loaded With $30M, Pursues Gene Therapy for Rare Diseases 07/26/13 San Francisco
Audentes Therapeutics Obtains $30,000,000 Series A Funding Round 07/19/13 San Francisco
Ceterix Comes Out With Tool to Repair, Not Remove, Knee Cartilage 07/16/13 San Francisco
Flexion’s Long-Lasting Steroid Injection Hits Mark in Phase 2 Trial 06/26/13 Boston
Venture Funding in Detroit Down in Q1, Still Higher Than 2011 04/19/13 Detroit Ann Arbor
Ceterix Orthopaedics Lands $19,500,000 Series B Round 01/22/13 San Francisco
Flexion Therapeutics Secures $20 Million to Fight Osteoarthritis 12/04/12 Boston
Flexion Therapeutics Obtains $20,000,000 Series B Funding 12/04/12 Boston
Pearl Therapeutics Secures $65,000,000 Series D Round 11/13/12 San Francisco
Pulmatrix Names Clarke CEO, Releases Promising Data on Lung Drug 09/04/12 Boston
Relypsa Gets Another $50M for Drug to Fight Excess Potassium 08/13/12 San Francisco
Atterocor Lands $16M Series A Round For Cancer Therapy 08/07/12 Detroit Ann Arbor
Atterocor Receives $16,000,000 Series A Financing Round 08/06/12 Detroit Ann Arbor
Igenica Pulls in $33M to Fight Cancer With Antibodies 06/12/12 San Francisco
Igenica Garners $33,000,000 Series C Financing Round 06/12/12 San Francisco
The Affymetrix Alumni: Where Are They Now? 05/02/12 San Francisco
Merck Returns to SD, Pouring $90M Into New Schultz-Led Institute 03/15/12 San Diego
Page 2 of 5 « previous page · next page »